We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$253M
(+51%)
Cap. Flow
+$268M
Cap. Flow
% of AUM
35.64%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$17.4M |
| 2 |
Apple
AAPL
|
+$7.52M |
| 3 |
Broadcom
AVGO
|
+$6.81M |
| 4 |
Bausch Health
BHC
|
+$5.93M |
| 5 |
NBIS
Nebius Group N.V.
NBIS
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$2.86M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$1.98M |
| 3 |
EGLE
Eagle Bulk Shipping Inc.
EGLE
|
+$1.84M |
| 4 |
ALTR
Altera Corp
ALTR
|
+$1.74M |
| 5 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.08% |
| 3 | Industrials | 11.83% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Teradata
TDC
$2.55B
| $656K | 0.09% |
17,727
+2,310
| +15% | +$95.1K |
|
|
VIVO
327
DELISTED
Meridian Bioscience Inc
VIVO
| $656K | 0.09% |
35,214
+1,789
| +5% | +$33.2K |
|
|
RTN
328
DELISTED
Raytheon Company
RTN
| $656K | 0.09% |
6,860
+605
| +10% | +$63.4K |
|
|
CTRX
329
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $656K | 0.09% |
10,741
+544
| +5% | +$32.6K |
|
330
Delek US
DK
$3.58B
| $654K | 0.09% |
17,766
+1,090
| +7% | +$40.9K |
|
331
Capitol Federal Financial
CFFN
$1.1B
| $653K | 0.09% |
54,230
+1,997
| +4% | +$24.3K |
|
332
CONMED
CNMD
$1.47B
| $653K | 0.09% |
11,213
+411
| +4% | +$22.2K |
|
333
West Pharmaceutical
WST
$24.9B
| $650K | 0.09% |
11,194
+411
| +4% | +$22.9K |
|
|
CMO
334
DELISTED
Capstead Mortgage Corp.
CMO
| $650K | 0.09% |
58,573
+2,790
| +5% | +$32.9K |
|
335
Dentsply Sirona
XRAY
$2.43B
| $649K | 0.09% |
12,581
+1,020
| +9% | +$52.8K |
|
|
COHR
336
DELISTED
Coherent Inc
COHR
| $647K | 0.09% |
10,192
+374
| +4% | +$24K |
|
337
Scholastic
SCHL
$792M
| $645K | 0.09% |
14,625
+698
| +5% | +$30K |
|
338
BWX Technologies
BWXT
$15.6B
| $643K | 0.09% |
27,399
+1,357
| +5% | +$31.9K |
|
|
PBCT
339
DELISTED
People's United Financial Inc
PBCT
| $643K | 0.09% |
39,649
+3,848
| +11% | +$59.8K |
|
|
PRE
340
DELISTED
PARTNERRE LTD
PRE
| $641K | 0.09% |
4,992
-4,630
| -48% | -$597K |
|
|
BRKL
341
DELISTED
Brookline Bancorp
BRKL
| $638K | 0.08% |
56,501
+2,789
| +5% | +$30.4K |
|
|
CYNO
342
DELISTED
Cynosure, Inc. Class A
CYNO
| $637K | 0.08% |
16,524
+892
| +6% | +$31.4K |
|
343
HP
HPQ
$27.5B
| $636K | 0.08% |
46,680
+5,846
| +14% | +$86.8K |
|
344
Kaiser Aluminum
KALU
$3.02B
| $636K | 0.08% |
7,658
-70
| -0.9% | -$5.69K |
|
|
MITT
345
TPG Mortgage Investment Trust
MITT
$225M
| $635K | 0.08% |
12,248
+638
| +5% | +$35.9K |
|
|
FNFG
346
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $635K | 0.08% |
67,246
+3,293
| +5% | +$30.1K |
|
347
Green Dot
GDOT
$745M
| $630K | 0.08% |
32,971
+1,819
| +6% | +$29.5K |
|
348
Marvell Technology
MRVL
$196B
| $630K | 0.08% |
47,783
-43,199
| -47% | -$620K |
|
349
MYR Group
MYRG
$5.25B
| $630K | 0.08% |
20,353
+1,324
| +7% | +$39.8K |
|
350
Forum Energy Technologies
FET
$835M
| $629K | 0.08% |
1,550
+73
| +5% | +$31.3K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q2 2015 Portfolio in Review
As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.
- Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
- Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
- Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
- Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
- Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
- Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
- Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.
Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.